Evid Invest

BMYMP vs ONC: Valuation Comparison 2026

Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from SEC filings.

Side-by-side fundamentals for Bristol-Myers Squibb Company PFD CONV 2 (BMYMP) and BeOne Medicines Ltd. (ONC) — market cap, PE, PEG and sector. All figures from SEC filings and market data.

Bristol-Myers Squibb Company PFD CONV 2

BMYMP

Healthcare

Full BMYMP valuation →

BeOne Medicines Ltd.

ONC

Healthcare

Full ONC valuation →
MetricBMYMPONC
SectorHealthcareHealthcare
IndustryDrug Manufacturers - GeneralBiotechnology
Current Price (Cboe, delayed)$400$372.49
Market Cap$814.59B$550.59B
PE Ratio87.91827.76
PEG Ratio16.51—
PEG VerdictPotentially OvervaluedN/A
BMYMP fair valueONC fair valueBMYMP supply chainONC supply chain

More comparisons

EvidInvest is an independent research and information tool. Figures are calculated from public SEC filings and third-party market data and are provided for informational and educational purposes only. EvidInvest does not provide investment advice, brokerage, or financial services, and is not affiliated with any company it covers. Verify all figures against primary sources before making any decision.